ArticleThe Journal of clinical and aesthetic dermatology2016

Results of a Phase 2 Efficacy and Safety Study with SB204, an Investigational Topical Nitric Oxide-releasing Drug for the Treatment of Acne Vulgaris.

Hilary Baldwin et al.PubMed ↗Full text ↗

No numbers read from the abstract.